(function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){ (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o), m=s.getElementsByTagName(o)[0];a.async=1;a.data-privacy-src=g;m.parentNode.insertBefore(a,m) })(window,document,'script','//www.google-analytics.com/analytics.js','ga'); ga('create', 'UA-1666707-3', 'auto'); ga('send', 'pageview');

Regulatory Affairs

Romania – Notice on Change of Access to Information on Centrally Authorised Medicinal Products

The NMA hereby informs you on replacement of PDF files in the “Useful Information” section of the main menu, containing the Romanian version of the Summary of Product Characteristics (SPC)

By |2020-04-01T12:49:09+01:00April 21st, 2009|Regulatory Affairs|0 Comments

Marketing Authorisation for Medicines via Centralised Procedure in Turkey

Marketing authorisation could be laso granted for Turkey to comapnies on-going cantalised procedure by EMEA, according to investigation of FarmavitaR+ consultant from Istanbul, Turkey. An application sould be filed in

By |2020-04-01T12:49:09+01:00February 2nd, 2008|Regulatory Affairs|0 Comments

Healthcare Brands International Announces the Acquisition of Antula Holdings AB

Healthcare Brands International (HBI) announces the completion of a major step towards its goal of building a new international Over-the-Counter (OTC) healthcare business with the acquisition of Antula Holdings AB,

By |2020-04-01T12:49:09+01:00January 8th, 2008|Regulatory Affairs|0 Comments

Readability (QRD) Testing of Patinet Information Leaflet (PIL)

Since 2005, marketing authorization holders of medicines are required to have the patient information leafets for their products readability tested. The European Directive 2004/27/EC (a revision of Directive 2001/83/EC) defines

By |2020-04-01T12:49:14+01:00June 4th, 2007|Regulatory Affairs|0 Comments

New Legal Framework for Harmonisation of the Data Exclusivity

The new periods of data exclusivity will only take effect for reference products applying for marketing authorisation after the new law is fully in effect (around November 2005). Therefore, the

By |2020-04-01T12:49:48+01:00November 29th, 2005|Regulatory Affairs|0 Comments
Go to Top